Drug Topics October 16, 2024
Brian Nowosielski

David Pope, PharmD, Chief Pharmacy Officer at XiFin, further discussed value-based care and his company’s ongoing collaboration with pharmacies across the country.

In part 2 of his interview with Drug Topics, David Pope, PharmD, Chief Pharmacy Officer at XiFin, dove deeper into the idea of value-based care. He broke down how it differs from the fee-for-service model—what most pharmacies and their employees are used to—and its current perception within the industry. While it isn’t necessarily adopted on a universal scale, according to Pope, pharmacy has been providing value-based care for years.

“I think plans have always thought that pharmacy was an ideal place [for value-based care models] because of the number of times they see the patient. It’s just always...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Interview / Q&A, Payment Models, Pharma, Pharma / Biotech, Trends, Value Based
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
Survey Suggests Pharma Industry Still Struggling with Digital Transformation
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights
Kura Oncology Gets $330M to Kick Off Global Leukemia Drug Pact With Kyowa Kirin
What might a Trump administration mean for the Biosecure Act?

Share This Article